Regencell Bioscience (NASDAQ:RGC) Stock Price Down 8.9% – What’s Next?

Shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 8.9% during mid-day trading on Tuesday . The stock traded as low as $27.13 and last traded at $28.10. 69,823 shares changed hands during trading, a decline of 83% from the average session volume of 409,729 shares. The stock had previously closed at $30.83.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Regencell Bioscience in a report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Regencell Bioscience currently has a consensus rating of “Sell”.

Regencell Bioscience Stock Performance

The business’s 50-day moving average price is $27.12 and its 200-day moving average price is $22.05.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of RGC. Seven Fleet Capital Management LP bought a new position in Regencell Bioscience in the 4th quarter worth $92,000. Hudson Bay Capital Management LP bought a new position in Regencell Bioscience in the 4th quarter worth $275,000. XTX Topco Ltd bought a new position in Regencell Bioscience in the 3rd quarter worth $598,000. Vident Advisory LLC boosted its holdings in Regencell Bioscience by 65.7% in the 4th quarter. Vident Advisory LLC now owns 29,934 shares of the company’s stock worth $629,000 after buying an additional 11,866 shares during the period. Finally, BNP Paribas Financial Markets bought a new position in Regencell Bioscience in the 2nd quarter worth $768,000. Institutional investors own 0.13% of the company’s stock.

Regencell Bioscience Company Profile

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.